Int J Stem Cells.  2016 May;9(1):1-2. 10.15283/ijsc.2016.9.1.1.

Questions Surrounding iPS Cells in Japan

• Yui Y

• KMID: 2164154
• DOI: http://doi.org/10.15283/ijsc.2016.9.1.1

Abstract

No abstract available.

MeSH Terms

Induced Pluripotent Stem Cells*
Japan*

Reference

References

1. Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, Makinoshima H, Goda M, Akashi H, Inutsuka A, Niwa A, Shigemoto T, Nabeshima Y, Nakahata T, Nabeshima Y, Fujiyoshi Y, Dezawa M. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA. 2010; 107:8639–8643. DOI: 10.1073/pnas.0911647107. PMID: 20421459. PMCID: 2889306.

2. Wakao S, Kitada M, Kuroda Y, Shigemoto T, Matsuse D, Akashi H, Tanimura Y, Tsuchiyama K, Kikuchi T, Goda M, Nakahata T, Fujiyoshi Y, Dezawa M. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci USA. 2011; 108:9875–9880. DOI: 10.1073/pnas.1100816108. PMID: 21628574. PMCID: 3116385.

3. Uchida H, Morita T, Niizuma K, Kushida Y, Kuroda Y, Wakao S, Sakata H, Matsuzaka Y, Mushiake H, Tominaga T, Borlongan CV, Dezawa M. Transplantation of unique subpopulation of fibroblasts, muse cells, ameliorates experimental stroke possibly via robust neuronal differentiation. Stem Cells. 2016; 34:160–173. DOI: 10.1002/stem.2206.

4. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131:861–872. DOI: 10.1016/j.cell.2007.11.019. PMID: 18035408.

5. Yamanaka S, Zhang XY, Maeda M, Miura K, Wang S, Farese RV Jr, Iwao H, Innerarity TL. Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway. EMBO J. 2000; 19:5533–5541. DOI: 10.1093/emboj/19.20.5533. PMID: 11032820. PMCID: 314019.

6. Yui Y. Concerns about the Jikei heart study. Lancet. 2012; 379:e48. DOI: 10.1016/S0140-6736(12)60599-6. PMID: 22500880.

7. Yui Y. Prevention of misconduct in clinical trials in Japan. Lancet. 2014; 384:1098. DOI: 10.1016/S0140-6736(14)61675-5. PMID: 25241720.